In high-risk patients with severe aortic stenosis, prosthesis-patient mismatch is more common following surgical aortic valve replacement (SAVR) than transcatheter aortic valve replacement (TAVR).
In patients who have undergone transcatheter aortic valve replacement (TAVR), the presence of an imbalance between prosthesis functioning and body size can lessen the positive hemodynamic impact of ...
Please provide your email address to receive an email when new articles are posted on . There was a low prevalence of prosthesis-patient mismatch and mortality 1 year in patients who underwent ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Severe prosthesis-patient mismatch conferred elevated risk for mortality and HF hospitalization at 1 ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- ...
SAN DIEGO — Severe prosthesis–patient mismatch (PPM) occurs in more than 10% of patients after transcatheter aortic valve replacement (TAVR) and increases the risk for death but not stroke, according ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BOSTON -- ...
Prosthesis–patient mismatch (PPM) occurs when a prosthetic aortic valve with a smaller effective orifice area (EOA) than that of the patient's native valve is implanted. PPM results in abnormally high ...
Prosthesis-patient mismatch — when a patient with aortic stenosis is given a valve prosthesis with an effective orifice area that is too small in relation to body size — is associated with higher risk ...
MINNEAPOLIS and BRISBANE, Australia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (AVR) (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) today released 30-day clinical outcomes ...
SAN DIEGO--In the largest multi-institutional study to date, led by researchers from Penn Medicine, the team found that among patients who underwent a transcatheter aortic valve replacement (TAVR), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results